Pfizer plans to kick off an auction process for its consumer healthcare business in November, paving the way for a potential $15 billion-plus sale of the headache pill to lip balm business, sources close to the matter told Reuters. Several global companies, including GlaxoSmithKline and Reckitt Benckiser, have expressed interest in bidding for the unit, which had sales of about $3.4 billion in 2016. The prospective sale, which is being led by Centerview Partners, Guggenheim Securities and Morgan Stanley, was first mooted on Oct 10, when Pfizer said it was considering strategic ...
Pfizer to start auction process for its consumer healthcare unit in Nov
The prospective sale was first mooted on Oct 10, when Pfizer said it was considering strategic options for the unit